MRI-Guided Neurosurgical Ablation Market Size, Share, Growth Analysis, By Product(MRI Guided RF Ablation Systems, MRI Guided Laser Ablation Systems, MRI Guided Focused Ultrasound Systems and Accessories), By End-use(Hospitals, Clinics and Ambulatory Surgical Centers), By Region - Industry Forecast 2024-2031

Global MRI-Guided Neurosurgical Ablation Market size was valued at USD 566.92 million in 2021 and is poised to grow from USD 608.31 million in 2022 to USD 1068.86 million by 2030, growing at a CAGR of 7.3% in the forecast period (2023-2030).

The growth of the market is due to the rising incidence of nervous system-related diseases and brain tumors, as well as the growing use of less invasive neurosurgery techniques. Moreover, the market is driven by the increasing use of minimally invasive neurosurgery treatments.

Because minimally invasive surgeries can advance recovery, patients are choosing them more. Neurosurgeons use a variety of specialized instruments to reduce tissue injury during these procedures. Compared to typical surgical approaches, this strategy lowers surgical risks and requires fewer incisions and instruments.

Furthermore, In February 2022, Researchers at UCL created a revolutionary cancer treatment that heats and destroys tumors by using an MRI scanner to direct a magnetic seed across the brain. This treatment eradicates the tumor accurately without damaging healthy tissues, potentially avoiding usual harmful effects.

In addition to reducing the number of notches needed, this procedure has the added benefit of cosmetically beating wounds. Applications for minimally aggressive techniques include the treatment of benign and malignant brain tumors.

These techniques are less intrusive, which allows surgeons to spend more time doing other surgeries and allows patients to recover more speedily. Because minimally invasive procedures have many profits over traditional treatment options, doctors are increasingly endorsing them to patients during neurosurgical surgeries.

Developments in high-resolution, real-time magnetic resonance imaging (MRI) have enhanced the accuracy and safety of neurosurgery procedures. These improvements have allowed surgeons to visualize the brain in real-time, display the ablation process, and change course throughout the procedure as necessary.

This tactic has reduced the risk of destructive healthy brain tissue while also improving patient consequences. For instance, in December 2022, physicians at UT Southwestern introduced an enhanced aiming technique known as four-tract tractography.

This innovation aims to adapt MRI-guided, high-intensity focused ultrasound (HIFU) treatments, which are utilized at UTSW for patients with medication-resistant tremors in essential tremor and tremor-dominant Parkinson's disease.

One of the high influences contributing to the growth of the market is the rising number of patients with brain tumors. According to the American Cancer Society, there will be almost 24,810 new instances of brain and other nervous system cancer in 2023, and there will be 18,990 estimated deaths from these cases.